Understanding how bacterial proteins interact with human cells to improve drug development
Biophysical understanding of pathogen-host membrane protein interactions for drug discovery and delivery
This study is looking at how certain proteins from bacteria interact with our body's cells to help us find new ways to create better antibiotics, especially since some bacteria are becoming resistant to the ones we have now.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11097190 on NIH RePORTER |
What this research studies
This research investigates the interactions between bacterial membrane proteins and human host cells, which are crucial for understanding bacterial infections. By studying the structure and function of these proteins, the research aims to uncover new insights that could lead to the development of more effective antibiotics. The approach combines biophysical techniques to analyze how these proteins operate and how they can be targeted for drug discovery. This work is particularly relevant as antibiotic resistance continues to rise, making it essential to find new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections, particularly those caused by pathogens like Neisseria gonorrhoeae and N. meningitidis.
Not a fit: Patients with viral infections or those not affected by bacterial pathogens may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that are effective against resistant bacterial infections.
How similar studies have performed: Previous research has shown promise in understanding bacterial membrane proteins, indicating that this approach could lead to significant advancements in antibiotic development.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Columbus, Linda M — University of Virginia
- Study coordinator: Columbus, Linda M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.